Cantor Fitzgerald Maintains Overweight on Eli Lilly, Raises Price Target to $1440

Benzinga Newsdesk www.benzinga.com Positive 82.1%

Neg 0% Neu 0% Pos 82.1%

Cantor Fitzgerald analyst Carter Gould maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1410 to $1440.